Clinical Trials Browser

Phase 2 × INDUSTRY × Hepatic Encephalopathy × Clear all

NCT00597909 2024-12-17

Efficacy and Safety Study of Ammonul® in Patients With Grade 3 or 4 Hepatic Encephalopathy

Phase 2 Terminated

Hepatic Encephalopathy, Lymphoma, Follicular